Merrick I. Ross
0000-0002-7787-0421
Publication & Citation Trends
Publications
0 total
Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma OA
Cited by 237
Semantic Scholar
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT) OA
Cited by 23
Semantic Scholar
Melanoma, version 4.2014. OA
Cited by 75
Semantic Scholar
Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma OA
Cited by 143
Semantic Scholar
Diversity of Stage III Melanoma in the Era of Sentinel Lymph Node Biopsy
Cited by 27
Semantic Scholar
Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer.
Cited by 45
Semantic Scholar
Lymphoscintigraphy as a predictor of lymphatic drainage from cutaneous melanoma
Cited by 25
Semantic Scholar
Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years.
Cited by 9
Semantic Scholar
Research Topics
Cutaneous Melanoma Detection and Management
(306)
Breast Cancer Treatment Studies
(132)
CAR-T cell therapy research
(130)
Immunotherapy and Immune Responses
(128)
Nonmelanoma Skin Cancer Studies
(97)
Affiliations
Dartmouth College
Northwestern University
Novartis (Switzerland)
MedStar Washington Hospital Center
Fox Chase Cancer Center